Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Sophie R Stroes

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 15, 2025
Reply to Letter to the Editor: 'ALT and Novel Fibrosis Scores for Risk Stratification of Pediatric MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2026
Reply to Letter to the Editor: 'Unaddressed Limitations of ALT as a Screening Tool for Paediatric Advanced MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics|November 19, 2024
Pediatric MASLD: current understanding and practical approachAnne-Sophie R Stroes, Miriam Vos, Marc A Benninga, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2025
ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and OverweightAnne-Sophie R Stroes, Laura Draijer, Malika Chegary, et al.
Obesity Research & Clinical Practice|December 28, 2025
Children's experience of screening and evaluation for MASLD in overweight and obesityAnne-Sophie R Stroes, Laura Draijer, Hedy A van Oers, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 15, 2025
Reply to Letter to the Editor: 'ALT and Novel Fibrosis Scores for Risk Stratification of Pediatric MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2026
Reply to Letter to the Editor: 'Unaddressed Limitations of ALT as a Screening Tool for Paediatric Advanced MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics|November 19, 2024
Pediatric MASLD: current understanding and practical approachAnne-Sophie R Stroes, Miriam Vos, Marc A Benninga, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2025
ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and OverweightAnne-Sophie R Stroes, Laura Draijer, Malika Chegary, et al.
Obesity Research & Clinical Practice|December 28, 2025
Children's experience of screening and evaluation for MASLD in overweight and obesityAnne-Sophie R Stroes, Laura Draijer, Hedy A van Oers, et al.
Pageof 1